3360 SHIP HEALTHCARE HOLDINGS, INC. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

3360

TSE Prime

SHIP HEALTHCARE HOLDINGS, INC.

2,079.0

JPY

+28.0

(+1.37%)

May 7, 3:30 pm JST

14.54

USD

May 7, 2:30 am EDT

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2021	497,156	21,800	21,761	12,280	130.0	40	May 11, 2021	J-GAAP
Mar, 2022	514,353	20,505	21,287	12,172	129.0	41	May 10, 2022	J-GAAP
Mar, 2023	572,285	21,144	20,607	12,063	127.9	42	May 12, 2023	J-GAAP
Mar, 2024	630,988	24,535	25,215	13,789	146.2	50	May 10, 2024	J-GAAP
Mar, 2025 Guidance	640,000	26,000	26,000	15,000	159.0	58	Mar 7, 2025	J-GAAP
YoY	+1.4%	+6.0%	+3.1%	+8.8%	+8.8%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2020	May 10, 2019	466,000	18,500	19,300	11,800	37.5	J-GAAP
Results	May 12, 2020	484,395	18,794	19,931	11,803	37.5	J-GAAP
Mar, 2021	May 12, 2020	Available in future release
Results	May 11, 2021
Mar, 2022	May 11, 2021
	Mar 4, 2022
Results	May 10, 2022
Mar, 2023	May 10, 2022
Results	May 12, 2023
Mar, 2024	May 12, 2023
	Nov 10, 2023
Results	May 10, 2024
Mar, 2025	May 10, 2024	640,000	26,000	26,000	15,000	53	J-GAAP
	Mar 7, 2025	640,000	26,000	26,000	15,000	58	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Apr, 2000	623	-15.1	Available in future release
Apr, 2001	425	-31.8
Mar, 2002 Changed	459	－
Mar, 2003	35,145	+7,556.9
Mar, 2004	44,045	+25.3
Mar, 2005	52,860	+20.0
Mar, 2006	62,229	+17.7
Mar, 2007	78,845	+26.7
Mar, 2008	105,871	+34.3
Mar, 2009	118,604	+12.0
Mar, 2010	140,009	+18.0
Mar, 2011	162,432	+16.0
Mar, 2012	188,839	+16.3
Mar, 2013	224,363	+18.8
Mar, 2014	259,189	+15.5
Mar, 2015	273,327	+5.5
Mar, 2016	306,853	+12.3
Mar, 2017	408,487	+33.1
Mar, 2018	425,566	+4.2
Mar, 2019	444,048	+4.3
Mar, 2020	484,395	+9.1
Mar, 2021	497,156	+2.6
Mar, 2022	514,353	+3.5
Mar, 2023	572,285	+11.3
Mar, 2024	630,988	+10.3
Mar, 2025 Guidance	640,000	+1.4	26,000	+6.0	26,000	+3.1	159.0	+8.8

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2023	572,285	21,144	3.69	9.79	3.36	1.60	127.9
Mar, 2024	630,988	24,535	3.89	10.31	3.58	1.64	146.2
Mar, 2025 Guidance	640,000	26,000	4.06	10.31	3.96	1.69	159.0

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	630,988	24,535	25,215	13,789	146.2
Fiscal Year	Mar, 2024	Mar, 2024	Mar, 2024	Mar, 2024	Mar, 2024

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2021	279,690	12,912	13,909	8,054	85.4	41	May 10, 2022	J-GAAP
Oct - Mar, 2022	308,765	13,173	13,109	7,920	83.9	42	May 12, 2023	J-GAAP
Oct - Mar, 2023	334,217	15,297	15,099	10,103	107.1	50	May 10, 2024	J-GAAP
Oct - Mar, 2024 Guidance	329,968	18,257	17,586	9,461	100.3	58	Mar 7, 2025	J-GAAP
YoY	-1.3%	+19.4%	+16.5%	-6.4%	-6.4%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2022	20,505	8,558	12,428	-3,870	-8,842	72,804	21.73	J-GAAP
Mar, 2023	21,144	7,331	14,105	-6,774	-1,022	79,020	20.69	J-GAAP
Mar, 2024	24,535	24,407	31,609	-7,202	-20,482	83,128	21.45	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	407,120	13,370	12,849	7,450	79.0	62.4	Feb 7, 2023	J-GAAP
Apr - Dec, 2023	453,057	15,130	15,788	7,224	76.6	62.6	Feb 9, 2024	J-GAAP
Apr - Dec, 2024	492,272	15,121	16,545	10,517	111.5	63.6	Feb 7, 2025	J-GAAP
YoY	+8.7%	-0.1%	+4.8%	+45.6%	+45.6%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2023	165,165	7,774	7,758	4,613	48.9	4.7	May 12, 2023	J-GAAP
Apr - Jun, 2023	146,467	3,842	4,648	2,998	31.8	2.6	Aug 8, 2023	J-GAAP
Jul - Sep, 2023	150,304	5,396	5,468	688	7.3	3.6	Nov 10, 2023	J-GAAP
Oct - Dec, 2023	156,286	5,892	5,672	3,538	37.5	3.8	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	177,931	9,405	9,427	6,565	69.6	5.3	May 10, 2024	J-GAAP
Apr - Jun, 2024	155,219	3,502	4,485	3,065	32.5	2.3	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	154,813	4,241	3,929	2,474	26.2	2.7	Nov 8, 2024	J-GAAP
Oct - Dec, 2024	182,240	7,378	8,131	4,978	52.8	4.0	Feb 7, 2025	J-GAAP
YoY	+16.6%	+25.2%	+43.4%	+40.7%	+40.7%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2020	126,394	-0.4	Available in future release
Apr - Jun, 2020	105,455	-3.3
Jul - Sep, 2020	115,276	-13.5
Oct - Dec, 2020	128,626	+11.1
Jan - Mar, 2021	147,799	+16.9
Apr - Jun, 2021	114,215	+8.3
Jul - Sep, 2021	120,448	+4.5
Oct - Dec, 2021	128,491	-0.1
Jan - Mar, 2022	151,199	+2.3
Apr - Jun, 2022	121,214	+6.1
Jul - Sep, 2022	142,306	+18.1
Oct - Dec, 2022	143,600	+11.8
Jan - Mar, 2023	165,165	+9.2
Apr - Jun, 2023	146,467	+20.8
Jul - Sep, 2023	150,304	+5.6
Oct - Dec, 2023	156,286	+8.8
Jan - Mar, 2024	177,931	+7.7
Apr - Jun, 2024	155,219	+6.0
Jul - Sep, 2024	154,813	+3.0
Oct - Dec, 2024	182,240	+16.6	7,378	+25.2	8,131	+43.4	52.8	+40.8

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	182,240	9,405	9,427	6,565	69.6
Fiscal Year	Dec, 2024	Mar, 2024	Mar, 2024	Mar, 2024	Mar, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2022	1,253.73	35.3	335,074	118,289	91,964	0.52	May 10, 2022	J-GAAP
Mar, 2023	1,357.05	33.5	381,977	128,037	100,158	0.58	May 12, 2023	J-GAAP
Mar, 2024	1,478.71	36.0	387,562	139,527	109,996	0.37	May 10, 2024	J-GAAP
Apr - Dec, 2024	ー	38.4	378,433	145,490	115,796	0.23	Feb 7, 2025	J-GAAP

SHIP HEALTHCARE HOLDINGS, INC.(3360) Financial Results